Dawai Bazaar Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 18-12-2024
- Paid Up Capital ₹ 0.10 M
as on 18-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit -104.18%
(FY 2020)
- Ebitda -104.18%
(FY 2020)
- Net Worth -123.45%
(FY 2020)
- Total Assets -0.87%
(FY 2020)
About Dawai Bazaar Pharma Solutions
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Priyanka Paul and Sanjit Paul serve as directors at the Company.
- CIN/LLPIN
U74900MH2016PTC272607
- Company No.
272607
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dawai Bazaar Pharma Solutions?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Paul  | Director | 03-Feb-2016 | Current |
| Sanjit Paul | Director | 03-Feb-2016 | Current |
Financial Performance of Dawai Bazaar Pharma Solutions.
Dawai Bazaar Pharma Solutions Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 104.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 123.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dawai Bazaar Pharma Solutions?
In 2020, Dawai Bazaar Pharma Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Professional Tpa Healthcare Services Private LimitedActive 8 years 4 monthsPriyanka Paul and Sanjit Paul are mutual person
Platinum Hospitals Private LimitedActive 13 years 5 monthsPriyanka Paul and Sanjit Paul are mutual person
Top Lawyers Legal And Consulting Private LimitedActive 7 years 10 monthsPriyanka Paul and Sanjit Paul are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dawai Bazaar Pharma Solutions?
Unlock and access historical data on people associated with Dawai Bazaar Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dawai Bazaar Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dawai Bazaar Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
